Bottom line
FBTCX vs RYOIX: the short answer
FBTCX (Fidelity Advisor Biotechnology Fund) and RYOIX (Biotechnology Fund) are both mutual funds.
RYOIX is cheaper at 1.38% vs 1.69% — a difference of $31 a year per $10,000 invested.
Over five years, FBTCX returned +6.8% a year vs +4.0% for RYOIX (reporting dates differ).
Updated Nov 19, 2026
FBTCX vs RYOIX side by side
| FBTCX | RYOIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | Guggenheim |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 1.69% | 1.38% |
| Annual cost per $10k | $169 | $138 |
| 10-yr cost on $10k (prospectus) | $1,799 | $1,709 |
| Max front load | — | — |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +37.5% | +30.7% |
| 5-yr return (annualized) | +6.8% | +4.0% |
| 10-yr return (annualized) | +7.7% | +5.9% |
| Best quarter | +30.3% | +28.3% |
| Worst quarter | −27.8% | −22.5% |
| Net assets (fund) | $2.2B | $136.8M |
| Number of holdings | 129 | 74 |
| Portfolio turnover | 54% | 75% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of FBTCX's top 25 holdings also appear in RYOIX's top 25.
| Holding | FBTCX | RYOIX |
|---|---|---|
| Abbvie Inc | 14.71% | 8.17% |
| Gilead Sciences Inc | 5.70% | 4.49% |
| Alnylam Pharmaceuticals Inc | 3.62% | 2.36% |
| Insmed Inc | 3.05% | 1.79% |
| Revolution Medicines Inc | 3.00% | 2.48% |
| Argenx Se | 3.00% | 1.48% |
| Biogen Inc | 2.71% | 2.13% |
| Amgen Inc | 2.37% | 5.05% |
| Moderna Inc | 1.60% | 2.15% |
| Natera Inc | 1.43% | 2.12% |
| Vertex Pharmaceuticals Inc | 1.39% | 4.32% |
Source: SEC Form N-PORT
FBTCX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
RYOIX top 10
- Abbvie Inc — 8.17%
- Amgen Inc — 5.05%
- Gilead Sciences Inc — 4.49%
- Vertex Pharmaceuticals Inc — 4.32%
- Regeneron Pharmaceuticals Inc — 2.93%
- Revolution Medicines Inc — 2.48%
- Alnylam Pharmaceuticals Inc — 2.36%
- Beone Medicines Ltd — 2.17%
- Moderna Inc — 2.15%
- Biogen Inc — 2.13%
FAQ
What is the difference between FBTCX and RYOIX?
FBTCX (Fidelity Advisor Biotechnology Fund) and RYOIX (Biotechnology Fund) are both mutual funds. RYOIX is cheaper at 1.38% vs 1.69% — a difference of $31 a year per $10,000 invested.
Which is cheaper, FBTCX or RYOIX?
RYOIX has the lower expense ratio (1.38%).
Should I own both FBTCX and RYOIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.